On January 23, 2026, Soligenix, Inc. entered into a Sales Agreement with Rodman & Renshaw to sell up to $3.45 million of its common stock as an at-the-market offering. This agreement allows for shares to be sold at prevailing market prices but does not obligate the company to issue any shares.